Novel Low Cost Bubble CPAP as an Alternative Respiratory Support in Low Resource Setting

Sponsor
Ilocos Training and Regional Medical Center (Other)
Overall Status
Completed
CT.gov ID
NCT06082674
Collaborator
(none)
70
1
2
8
8.7

Study Details

Study Description

Brief Summary

This is a single-blind randomized controlled trial done in a Level III neonatal intensive care unit. Preterm newborns with RDS were randomized to receive oxygen therapy through bubble CPAP vs ventilator-derived CPAP. Differences in arterial blood gases, oxygen saturation, number of surfactant and CPAP failure rate between study groups were analyzed.

Condition or Disease Intervention/Treatment Phase
  • Device: Vayu bCPAP
  • Device: Mechanical Ventilator Driven CPAP
Phase 2

Detailed Description

Background and Objective: Respiratory distress syndrome (RDS) among premature infants is one of the major causes of neonatal death. The use of continuous positive airway pressure (CPAP) has become a standard of care for preterm newborns with RDS. In countries faced with the challenge of improving neonatal care, cost-effective innovations for respiratory support are a promising intervention. This study determined the efficacy of a low-cost bubble CPAP as an alternative non-invasive oxygen therapy for newborn infants with RDS.

METHODS: This is a single-blind randomized controlled trial done in a Level III neonatal intensive care unit. Preterm newborns with RDS were randomized to receive oxygen therapy through bubble CPAP vs ventilator-derived CPAP. Differences in arterial blood gases, oxygen saturation, number of surfactant and CPAP failure rate between study groups were analyzed.

Study Design

Study Type:
Interventional
Actual Enrollment :
70 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Investigator, Outcomes Assessor)
Masking Description:
The study Blinded the investigator and outcome assesors
Primary Purpose:
Treatment
Official Title:
Novel Low Cost Bubble CPAP as an Alternative Non-invasive Respiratory Support Among Preterm Infants With Respiratory Distress Syndrome
Actual Study Start Date :
Apr 1, 2022
Actual Primary Completion Date :
Nov 15, 2022
Actual Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Vayu CPAP Group

The patients will be hooked to VAYu bCPAP

Device: Vayu bCPAP
The Vayu bCPAP uses a constant flow of dry oxygen from the source with an adjustable flow meter. Oxygen is blended by Venturi blender with ambient air to create a source of oxygen-enriched air of adjustable concentration.

Active Comparator: Mechanical Ventilator Driven CPAP

Patients will be hooked to Mechanical Ventilator Driven CPAP

Device: Mechanical Ventilator Driven CPAP
Mechanical Ventilator Driven CPAP

Outcome Measures

Primary Outcome Measures

  1. Partial pressure of arterial oxygen (pa02) using Arterial Blood Gas [8 months]

    Difference in the Partial pressure of arterial oxygen (pa02) using Arterial Blood Gas

  2. Partial pressure of carbon dioxide (pC02) using Arterial Blood Gas [8 months]

    Difference in the Partial pressure of carbon dioxide (pC02) using Arterial Blood Gas

  3. Oxygen Saturation [8 months]

    Difference in the oxygen saturation using pulse oximeter

Secondary Outcome Measures

  1. CPAP Failure [8 months]

    Difference in the number of CPAP failure

  2. surfactant use [8 months]

    total number of surfactant use

Eligibility Criteria

Criteria

Ages Eligible for Study:
5 Minutes to 6 Hours
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Included are preterm neonates less than 36 weeks (WHO definition)

  • admitted at NICU

  • APGAR scores of > 7 in the 1st and 5th minute of life

  • in respiratory distress at birth,

  • radiologic findings of RDS

  • Respiratory Severity Score (RSS) or Downe's score > 4 at 10-15 minutes after hooking to CPAP

  • requiring CPAP or more than 40% FiO2

Exclusion Criteria:
  • Infants requiring neonatal resuscitation such as bag mask ventilation, chest compression or intubation at birth

  • with comorbidities such as facial anomalies, tracheoesophageal fistulas, congenital heart disease, and other congenital anomalies which may interfere with the interface of both devices.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Ilocos Training and Regional Medical Center San Fernando La Union Philippines 2500

Sponsors and Collaborators

  • Ilocos Training and Regional Medical Center

Investigators

  • Principal Investigator: Navid Roodaki, MD, Ilocos Training and Regional Medical Center

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Navid Roodaki, Dr., Ilocos Training and Regional Medical Center
ClinicalTrials.gov Identifier:
NCT06082674
Other Study ID Numbers:
  • ITRMC-REC-2022-11
First Posted:
Oct 13, 2023
Last Update Posted:
Oct 13, 2023
Last Verified:
Oct 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 13, 2023